What is the total ACHV share position reported for Royston Aaron?

The Form 3 states that total shares of Achieve Life Sciences, Inc. common stock following the reported entry are 0.0000. This means Royston Aaron reported no beneficial ownership of company securities as of the transaction date disclosed.

Achieve Life Sciences (ACHV) director Royston Aaron reports zero share ownership

Q: What does Royston Aaron’s Form 3 for ACHV disclose?

The filing shows that director Royston Aaron currently has no securities beneficially owned in Achieve Life Sciences, Inc. It reports total shares following the holdings entry as 0.0000, indicating a zero ownership position at the time of this disclosure.

Q: Did Royston Aaron buy or sell ACHV shares in this Form 3?

No specific buy or sell transaction is reported. The Form 3 records a holdings entry with total shares following the transaction at 0.0000 and transaction direction marked as unknown, indicating this is strictly an initial ownership disclosure.

Q: What role does Royston Aaron hold at Achieve Life Sciences (ACHV)?

The filing identifies Royston Aaron as a director of Achieve Life Sciences, Inc. Being a director makes him a reporting person under SEC rules, requiring disclosure of his beneficial ownership on Form 3, even when that ownership is currently zero.

Q: Does the ACHV Form 3 show any derivative securities for Royston Aaron?

No derivative securities are listed in the derivativeSummary . The data show an empty derivative position and indicate that no options, warrants, or other derivative securities are currently reported as beneficially owned by Royston Aaron in this initial Form 3.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Achieve Life Sciences, Inc. director Royston Aaron filed an initial Form 3 indicating that he currently has no securities beneficially owned in the company. The filing lists total shares following the reported holdings entry as 0.0000, so this is a position disclosure rather than a buy or sell transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Royston Aaron

Role null

Type	Security	Shares	Price	Value
holding	No securities are beneficially owned	--	--	--

Holdings After Transaction: No securities are beneficially owned — 0 shares (Direct, null)

Footnotes (1)

Key Figures

Shares beneficially owned: 0.0000 shares

1 metrics

Shares beneficially owned 0.0000 shares Total shares following reported holdings entry

Key Terms

Form 3, beneficially owned, reporting person

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficially owned financial

"security_title": "No securities are beneficially owned""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

reporting person regulatory

""reportingPersons": [{"name": "Royston Aaron""

Understanding Insider Trading Forms →

04/27/2026 - 04:30 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Royston Aaron

(Last)

(First)

(Middle)

22722 29TH DR. SE

SUITE 100

(Street)

BOTHELL

WASHINGTON

98021

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/17/2026

3. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

	Sandra Thomson as attorney-in-fact for Aaron Royston	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Royston Aaron’s Form 3 for ACHV disclose?

The filing shows that director Royston Aaron currently has no securities beneficially owned in Achieve Life Sciences, Inc. It reports total shares following the holdings entry as 0.0000, indicating a zero ownership position at the time of this disclosure.

Did Royston Aaron buy or sell ACHV shares in this Form 3?

No specific buy or sell transaction is reported. The Form 3 records a holdings entry with total shares following the transaction at 0.0000 and transaction direction marked as unknown, indicating this is strictly an initial ownership disclosure.

What role does Royston Aaron hold at Achieve Life Sciences (ACHV)?

The filing identifies Royston Aaron as a director of Achieve Life Sciences, Inc. Being a director makes him a reporting person under SEC rules, requiring disclosure of his beneficial ownership on Form 3, even when that ownership is currently zero.

Does the ACHV Form 3 show any derivative securities for Royston Aaron?

No derivative securities are listed in the derivativeSummary. The data show an empty derivative position and indicate that no options, warrants, or other derivative securities are currently reported as beneficially owned by Royston Aaron in this initial Form 3.